Quinaprilat

Quinaprilat

SCHEMBL6438000

CC(N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 15/20 1.00
▸ ABCB11 O95342 1/20 0.82
▸ PDE3A Q14432 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinaprilat SCHEMBL11306348 1.00 ACE (1.00) ACEABCB11PDE3A
Quinaprilat SCHEMBL7392611 1.00 ACE (1.00) ACEABCB11PDE3A
Quinaprilat SCHEMBL11286565 1.00 ACE (1.00) ACEABCB11PDE3A
Quinaprilat SCHEMBL7421419 1.00 ACE (1.00) ACEABCB11PDE3A
Quinaprilat SCHEMBL113237 1.00 ACE (1.00) ACEABCB11PDE3A
Quinaprilat SCHEMBL29598971 1.00 ACE (1.00) ACEABCB11PDE3A
Quinaprilat SCHEMBL11286571 1.00 ACE (1.00) ACEABCB11PDE3A
Quinaprilat SCHEMBL9253792 1.00 ACE (1.00) ACEABCB11PDE3A
Quinaprilat SCHEMBL27697059 0.99 ACE (0.98) ACEABCB11PDE3A
Quinaprilat SCHEMBL27717008 0.99 ACE (0.98) ACEABCB11PDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050181066-A1 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency ALTANA PHARMA AG (DE) 2005-08-18 — — US disclosed
EP-1501605-A1 NOVEL USE OF GUANYLATE CYCLASE ACTIVATORS FOR THE TREATMENT OF RESPIRATORY INSUFFICIENCY ALTANA Pharma AG (DE) 2005-02-02 — — EP disclosed
WO-2003090870-A1 NOVEL USE OF GUANYLATE CYCLASE ACTIVATORS FOR THE TREATMENT OF RESPIRATORY INSUFFICIENCY ALTANA PHARMA AG (DE) 2003-11-06 — — WO disclosed
Send feedback